Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-07-10

Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 trial evaluating adoptive transfer of tumor infiltrating lymphocytes (TIL) for biliary tract cancers, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adoptive transfer of tumor infiltrating lymphocytes (TIL)

Snippet

Sponsor: Udai Kammula | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 | Status: RECRUITING